OctariusRx

OCTOBER 2, 2023

Join the OctariusRx team in supporting the American Cancer Society in this worthy cause. Find out how much you know about breast cancer by taking the quiz provided by the American Cancer Society. However, most women with breast cancer do not have a first-degree relative with the disease. You can start by testing your knowledge.

88

88

STAT

MARCH 6, 2023

… A two-part message is permeating the halls of medicine and the fabric of society, sliding into medical school lectures, pediatrician offices, happy hours, and social feeds: Obesity is a chronic biological disease — and it is treatable with a new class of medications , STAT explains. The

Medical Schools 86

Medical Schools Pharmaceutical Companies Pharmaceutical Companies 86

pharmaphorum

FEBRUARY 8, 2022

Novo Nordisk’s new obesity therapy Wegovy has been recommended for routine NHS use by UK cost-effectiveness watchdog NICE, but in a narrower group of patients than is covered by its MHRA-approved label. The 2019 Health Survey for England estimated 28% of adults in England were obese and a further 36% were overweight, according to NICE.

Labelling 105

Labelling 105

STAT

DECEMBER 13, 2023

employers facing surging costs from paying for Novo Nordisk’s Wegovy and similar obesity drugs are hiring virtual health care providers like Teladoc to implement weight-loss management programs , according to Reuters , which spoke with a dozen consultants, pharmacy benefit managers, analysts, and health care providers. … U.S.

Hospitals 97

Hospitals 97

OctariusRx

OCTOBER 3, 2022

Being overweight or obese, especially if weight is gained after menopause. To learn more about breast cancer risk factors and the steps you can take to help reduce your risk, visit the American Cancer Society® website at cancer.org/breastcancer or call them at 1-800-227-2345. Drinking alcohol, especially more than one drink a day.

77

77

STAT

JUNE 7, 2023

 government will launch a $50 million pilot program to explore how new weight-loss drugs such as Novo Nordisk’s Wegovy can be given to more obese patients outside of specialist services in hospitals , Reuters writes. Have a wonderful day, and please do stay in touch. … The U.K. government The move comes after the U.K.’s

Vaccines 74

Vaccines Hospitals Patient Care 74

The Checkup by Singlecare

JANUARY 31, 2024

They include: Obesity and excess weight: Weight gain and obesity , especially around the chest and abdomen, have been linked to asthma development. Risk factors for nighttime asthma In addition to these potential causes, several risk factors make someone more likely to experience nocturnal asthma symptoms.

105

105

Dr. Jamie Hardy: The Lifestyle Pharmacist

OCTOBER 9, 2023

Maintain a Healthy Weight: Obesity is associated with an increased risk of breast cancer. There are numerous resources available to provide support and information, including: National Breast Cancer Foundation ([link] American Cancer Society ([link] Breast Cancer Research Foundation ([link] Remember, knowledge is power.

52

52

The Checkup by Singlecare

OCTOBER 6, 2023

According to the recommendations by the Endocrine Society , all oral contraceptive alternatives appear to be equally effective for hirsutism , and the risk of side effects is low. Endocrine disorders like PCOS and obesity often go hand in hand. These guidelines also state that the anti-androgen alternatives are equally effective.

Labelling 52

Labelling FDA Dosage 52

NICE

JUNE 15, 2023

At NICE, we define health inequalities as unfair and avoidable differences in health across the population and between different groups of society. billion a year, and society around £31 billion in lost productivity. There is an economic impact too, with estimates suggesting health inequalities cost the NHS an extra £4.8

Hospitals 52

Hospitals 52

The Checkup by Singlecare

JANUARY 25, 2023

Improved blood pressure Being overweight or obese raises your risk for heart disease. Obesity is closely associated with obstructive sleep apnea. Research also suggests that bariatric surgery could be the right option for some people with moderate to severe obesity. Fortunately, slimming down can help with both of these issues.

Mayo Clinic 98

Mayo Clinic Insurance 98

pharmaphorum

AUGUST 11, 2020

“Whilst our treatments will help manage symptoms – and maybe one day offer a cure – we also recognise that these are unsustainable chronic conditions for society. The solution to obesity isn’t just ‘exercise more’. There are various triggers for why obesity happens, and more and more factors are starting to be understood.

Packaging 110

Packaging Communication 110

The Checkup by Singlecare

JANUARY 18, 2024

It is one of the most common neurological disorders in our society. Poor nutrition and being overweight or obese are correlated to increased frequency of headaches as well. The World Health Organization estimates that half the world’s adult population has had at least one headache in the last 12 months.

52

52

The Checkup by Singlecare

DECEMBER 5, 2023

Individuals with obesity or Type 2 diabetes are more likely to have high cholesterol, which increases the risk of heart disease, heart attack, and stroke. Over 11% of adults in the Hoosier State have diabetes, and over 35% have obesity. The only statin that’s slightly more effective than atorvastatin is rosuvastatin ( Crestor ).

Mayo Clinic 105

Mayo Clinic Department of Veterans Affairs Labelling Medical Schools 105

The Checkup by Singlecare

OCTOBER 20, 2023

Reduce aging “Fulvic acid, found in shilajit, may be effective in preventing cellular damage and damage caused by free radicals—the main culprits for the acceleration of aging symptoms,” says Praveen Guntipalli , MD, a double-board-certified physician in internal medicine and obesity and the medical director of Sanjiva Medical Spa in Dallas.

Immunization 105

Immunization FDA 105

The Checkup by Singlecare

AUGUST 11, 2023

Some of the medications associated with night sweats include: Aspirin Tylenol ( acetaminophen ) Certain medications that treat high blood pressure Certain antidepressants Nolvadex ( tamoxifen ) Lupron ( leuprolide ) Niacin The International Hyperhidrosis Society has a more extensive list here.

97

97

STAT

APRIL 24, 2024

One study from the American Society of Health-System Pharmacists found that GLP-1 treatments were a main driver of the increase in overall drug spending by health entities such as pharmacies and hospitals last year. billion, making the drug the top-selling medicine in 2023.

Hospitals 111

Hospitals 111

pharmaphorum

JUNE 8, 2022

To compound matters, the population demographic most at risk for lack of sleep are the older members of society who are also the most likely to have existing health problems. Research in the UK found that lower productivity due to lack of sleep could be costing the economy up to £40 billion per year. Why is sleep being discussed more?

Compounding 95

Compounding 95

The Checkup by Singlecare

DECEMBER 29, 2023

There are many causes of heartburn, from medications like calcium channel blockers to health conditions such as obesity. It typically originates in the esophagus (the tube connecting your mouth to your stomach), and it happens most often after eating or at night. Alcohol can be a powerful potent heartburn trigger, too.

Mayo Clinic 105

Mayo Clinic Compounding 105

European Pharmaceutical Review

JULY 5, 2022

There is also strong evidence that suggests being overweight or obese increases the risk of stomach cancer, and some bacterial and viral infections are under investigation for their potential contribution to disease risk. 3 However, it is not yet regulatory approved in the US or EU for treating gastric cancer.

Chemotherapy 86

Chemotherapy Dosage Labelling Compounding 86

pharmaphorum

JUNE 25, 2021

Meanwhile, the European Society of Cardiology has called for a more integrated approach to managing CVD and comorbidities, and the NHS has set out a CVD prevention strategy to avert 150,000 heart attacks and strokes over ten years. “I But there are still very high rates of obesity, smoking and inactivity.

Communication 83

Communication 83

STAT

APRIL 24, 2024

 One study from the American Society of Health-System Pharmacists found that GLP-1 treatments were a main driver of the increase in overall drug spending by health entities such as pharmacies and hospitals last year. billion, making the drug the top-selling medicine in 2023.

Compounding 82

Compounding Insurance Hospitals 82

The Thyroid Pharmacist

OCTOBER 7, 2022

The majority of the studies to date have come to the conclusion that those with diabetes, high blood pressure, and obesity can benefit from using stevia. Sugar consumption, metabolic disease and obesity: The state of the controversy. Stevia, Nature’s Zero-Calorie Sustainable Sweetener: A New Player in the Fight Against Obesity.

Immunization 92

Immunization Labelling Compounding FDA 92

The Guardian - Pharmaceutical Industry

JANUARY 6, 2024

The Bedfordshire town is one of the UK’s worst spots for obesity , with one hospital admission linked to weight for every 20 residents in 2022. McDonald’s is busy with shoppers, while chains from Subway to German Doner Kebab are opening their doors for the approaching army of hungry stomachs.

Hospitals 84

Hospitals 84

The Guardian - Pharmaceutical Industry

JULY 8, 2023

Observer investigation raises concerns about the influence of drugs companies in shaping patient care in services that use their products Pharmaceutical giants are pouring tens of millions of pounds into struggling NHS services – including paying the salaries of medical staff and funding the redesign of patient treatment – as they seek to boost drug (..)

Patient Care 99

Patient Care 99

The Checkup by Singlecare

DECEMBER 7, 2023

Not getting enough sleep has been linked to the development of several chronic conditions including Type 2 diabetes, hypertension, high cholesterol, and obesity. The American Academy of Sleep Medicine recommends at least seven hours of sleep each night for adults. Roughly 1 in 3 people in the U.S.

Dosage 52

Dosage FDA Labelling 52

The Guardian - Pharmaceutical Industry

JANUARY 31, 2024

Market value of Danish drugmaker behind Wegovy and Ozempic tops $500bn as demand soars Novo Nordisk shares hit a record high after the Danish company reported soaring sales of its obesity and diabetes drugs Wegovy and Ozempic, pushing its market value past $500bn and cementing its position as Europe’s most valuable company.

65

65

The Guardian - Pharmaceutical Industry

APRIL 9, 2023

A lifestyle approach developed by Dr David Unwin shows benefits that could have significant health implications A red-brick surgery in the seaside resort of Southport in the north-west of England is on the frontline of one of the biggest questions facing the NHS: what’s the best fix for our growing obesity crisis?

98

98

The Guardian - Pharmaceutical Industry

APRIL 30, 2023

But healthcare professionals fear it ignores the underlying socioeconomic causes Like many GPs around the UK, Semiya Aziz has grown accustomed to seeing children as young as four or five who are obese.

91

91

The Guardian - Pharmaceutical Industry

JANUARY 25, 2024

Mounjaro will come in a four-dose device known as a KwikPen for people with type 2 diabetes or obesity A new weight loss injection will be available in the UK within weeks to treat thousands of patients with type 2 diabetes or obesity, after the medicines watchdog became the first major regulator in the world to greenlight the drug in a more convenient (..)

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies 56

The Checkup by Singlecare

FEBRUARY 6, 2023

According to the Anxiety & Depression Society of America , almost 40 million people in the United States, or 18% of people, experience an anxiety disorder in a given year. Insomnia can be short-term (lasting for less than 3 months), or long-term (occurring at least 3 days a week for 3 months or more). Anxiety is common , too.

Controlled Substances 98

Controlled Substances Labelling FDA Communication 98

pharmaphorum

JANUARY 23, 2023

It costs society, as well. The real impact on society and the morale of health systems […] We need to change our lifestyle trajectory right now.” For some, a pill is a perfect solution, but obesity is a complicated condition. Many policies in obesity management have failed. A root-and-branch review is needed.

94

94

The Checkup by Singlecare

OCTOBER 27, 2023

Some factors can increase breast cancer risk , such as increasing age, obesity, or family history. People who meet any of the following criteria may have a high risk of getting breast cancer: Drinking alcohol Old age Having a family history of breast cancer Obesity ( WHO , 2023) What percentage of breast biopsies are cancer?

Chemotherapy 98

Chemotherapy Insurance Coverage Insurance Communication 98

The Guardian - Pharmaceutical Industry

APRIL 30, 2023

Department of Health asks watchdog to assess effectiveness of giving semaglutide to obese youngsters aged 12 to 17 Children as young as 12 in England could be given weight-loss injections on the NHS after the government asked medical watchdog Nice to assess the potential benefits of prescribing them to under-18s. Continue reading.

73

73

The People's Pharmacy

MAY 1, 2023

Another example: Mentioning to an obese customer the need to lose weight is a huge minefield that most pharmacists avoid at all costs. Skeptical Pharmacist #11: Our society is often too quick to name-and-blame rather than admit that many social and physical challenges in life are not best solved through prescribing another medication.

Health and Personal Care Stores 64

Health and Personal Care Stores Insurance Refill Authorization Insurance Coverage 64

The Guardian - Pharmaceutical Industry

NOVEMBER 2, 2023

Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company Business live – latest updates The maker of blockbuster weight-loss drug semaglutide has reported a steep rise in sales and profits as health systems around the world rush to use it to tackle obesity.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The Guardian - Pharmaceutical Industry

APRIL 25, 2023

A boom in injectable weight-loss drugs, such as Wegovy from the Danish pharmaceutical giant Novo Nordisk, a biological type 2 diabetes medication containing semaglutide, has promised to revolutionise obesity treatment in recent months.

Vaccines 66

Vaccines 66